Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2016-05-02 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BRAY-SUR-SEINE (77480), Seine-et-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA HALLE DE BRAY : revenue, balance sheet and financial ratios
PHARMACIE DE LA HALLE DE BRAY is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BRAY-SUR-SEINE (77480),
this company of category PME
shows in 2022 a revenue of 6.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA HALLE DE BRAY (SIREN 820056893)
Indicator
2023
2022
2021
2020
2018
2017
2016
Revenue
N/C
6 557 376 €
N/C
N/C
N/C
N/C
N/C
Net income
268 930 €
458 170 €
646 978 €
468 361 €
285 026 €
9 358 €
-129 533 €
EBITDA
N/C
800 298 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
7.0%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE DE LA HALLE DE BRAY generates positive net income of 269 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
268 930 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 271%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 22%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
271.374%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
22.265%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA HALLE DE BRAY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2020
2021
2022
2023
Debt ratio
-2111.695
-2273.381
3077.155
425.373
341.504
293.979
271.374
Financial autonomy
-4.189
-4.015
2.801
16.491
19.548
21.141
22.265
Repayment capacity
None
None
None
None
None
6.517
None
Cash flow / Revenue
None%
None%
None%
None%
None%
8.141%
None%
Sector positioning
Debt ratio
271.372023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average
In 2023, the debt ratio of PHARMACIE DE LA HALLE DE ... (271.37) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
22.27%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of PHARMACIE DE LA HALLE DE ... (22.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
6.52 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DE LA HALLE DE ... (6.52) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 72.26. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
72.26
Liquidity indicators evolution PHARMACIE DE LA HALLE DE BRAY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2020
2021
2022
2023
Liquidity ratio
152.069
122.86
120.024
107.398
112.648
61.95
72.26
Interest coverage
None
None
None
None
None
5.092
None
Sector positioning
Liquidity ratio
72.262023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Watch-6 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE DE LA HALLE DE ... (72.26) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
5.09x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good
In 2022, the interest coverage of PHARMACIE DE LA HALLE DE ... (5.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA HALLE DE BRAY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2020
2021
2022
2023
Operating WCR
0 €
0 €
0 €
0 €
0 €
300 787 €
0 €
Inventory turnover (days)
0
0
0
0
0
21
0
Customer payment term (days)
0
0
0
0
0
5
0
Supplier payment term (days)
0
0
0
0
0
50
0
Positioning of PHARMACIE DE LA HALLE DE BRAY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DE LA HALLE DE BRAY is estimated at
3 173 233 €
(range 1 929 794€ - 4 460 853€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1929k€3173k€4460k€
3 173 233 €Range: 1 929 794€ - 4 460 853€
NAF 5 année 2023
Valuation method used
Net Income Multiple
268 930 €
×
11.8x
=3 173 233 €
Range: 1 929 795€ - 4 460 854€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA HALLE DE BRAY with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA HALLE DE BRAY
What is the revenue of PHARMACIE DE LA HALLE DE BRAY ?
The revenue of PHARMACIE DE LA HALLE DE BRAY in 2022 is 6.6 M€.
Is PHARMACIE DE LA HALLE DE BRAY profitable?
Yes, PHARMACIE DE LA HALLE DE BRAY generated a net profit of 269 k€ in 2023.
Where is the headquarters of PHARMACIE DE LA HALLE DE BRAY ?
The headquarters of PHARMACIE DE LA HALLE DE BRAY is located in BRAY-SUR-SEINE (77480), in the department Seine-et-Marne.
Where to find the tax return of PHARMACIE DE LA HALLE DE BRAY ?
The tax return of PHARMACIE DE LA HALLE DE BRAY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA HALLE DE BRAY operate?
PHARMACIE DE LA HALLE DE BRAY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart